Felodipine β-cyclodextrin complex as an active core for time delayed chronotherapeutic treatment of hypertension

1. B. Lemmer, Circadian rhythms and drug delivery, J. Control. Release 16 (1991) 63-74; DOI: 10.1016/0168-3659(91)90031-8.10.1016/0168-3659(91)90031-8Search in Google Scholar

2. T. Bussemer, I. Otto and R. Bodmeier, Pulsatile drug delivery systems, Crit. Rev. Ther. Drug. 18 (2001) 433-458.10.1615/CritRevTherDrugCarrierSyst.v18.i5.10Search in Google Scholar

3. T. Bussemer, A. Dashevsky and R. Bodmeier, A pulsatile drug delivery system based on rupturable coated hard gelatin capsules, J. Control. Release 93 (2003) 331-339; DOI: 10.1016/i.jconrel. 2003.08.012.Search in Google Scholar

4. H. S. Michael and A. P. Nicholas, Chronobiology, drug delivery and chronotherapeutics, Adv. Drug Del. Rev. 59 (2007) 828-851; DOI: 10.1016/j.addr.2007.07.001.10.1016/j.addr.2007.07.00117884237Search in Google Scholar

5. A. S. Mandal, N. Biswas, K. M. Karim, A. Guha, S. Chatterjee, M. Behera and K. Kuotsn, Drug delivery system based on chronobiology-A review, J. Control. Release 147 (2010) 314-325; DOI: 10.1016/j.jconrel.2010.07.122.10.1016/j.jconrel.2010.07.12220691738Search in Google Scholar

6. B. C. Youan, Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? J. Control. Release 98 (2004) 337-353; DOI: 10.1016/j.jconrel.2004.05.015.10.1016/j.jconrel.2004.05.01515312991Search in Google Scholar

7. United States Pharmacopoeia 30, National Formulary 24, The United States Pharmacopoeial Convention, Rockville 2006, pp. 884-885.Search in Google Scholar

8. V. I. Teberekidis and M. P. Sigalas, Theoretical study of hydrogen bond interactions of felodipine with polyvinylpyrrolidone and polyethyleglycol, J. Mol. Struc-THEOCHEM. 803 (2007) 29-38; DOI: 10.1016/j.theochem.2006.09.016.10.1016/j.theochem.2006.09.016Search in Google Scholar

9. M. Yasir, M. Asif, A. Kumar and A. Aggarval, Biopharmaceutical classification system: An account, Int. J. Pharm. Tech. Res. 2 (2010) 1681-1690.Search in Google Scholar

10. B. Abrahamsson, D. Johansson, A. Torstensson and K. Wingstrand, Evaluation of solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine, Pharm. Res. 11 (1994) 1093-1097.10.1023/A:1018920412020Search in Google Scholar

11. A. T. M. Serajuddin, Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs, J. Pharm. Sci. 88 (1999) 1058-1066.Search in Google Scholar

12. D. M. Bramhane, N. S. Saindane and P. R. Vavia, Inclusion complexation of weakly acidic NSAID with b-cyclodextrin: selection of arginine, an amino acid, as a novel ternary component, J. Incl. Phenom. Macro. 69 (2010) 453-460.Search in Google Scholar

13. J. Mielcarek, A. Czernielewska and B. Czarczynska, Inclusion complexes of felodipine and amlodipine with methyl-b-cyclodextrin, J. Incl. Phenom. Macro. 54 (2006) 17-21.10.1007/s10847-005-2603-9Search in Google Scholar

14. M. E. Brewster and T. Loftsson, Cyclodextrins as pharmaceutical solubilizers, Adv. Drug Del. Rev. 59 (2007) 645-666.10.1016/j.addr.2007.05.01217601630Search in Google Scholar

15. E. Karavas, E. Georgarakis and D. Bikiaris, Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics, Eur. J. Pharm. Biopharm. 64 (2006) 115-126.10.1016/j.ejpb.2005.12.01316675210Search in Google Scholar

16. L. M. Prisant, Hypertension and chronotherapy: Shifting the treatment paradigm, Am. J. Hypertens. 14 (2001) 277S-279S.10.1016/S0895-7061(01)02173-2Search in Google Scholar

17. E. Karavas, E. Georgarakis and D. Bikiaris, Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer, Int. J. Pharm. 313 (2006) 189-197.10.1016/j.ijpharm.2006.01.015Search in Google Scholar

18. T. Higuchi and K. A. Connors, Phase-solubility Techniques, in Advances in Analytical Chemistry and Instrumentation, Wiley Interscience Publisher, New York 1965, pp. 117-212.Search in Google Scholar

19. E. Karavas, E. Georgarakis, M. P. Sigalas, K. Avgoustakis and D. Bikiaris, Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophobic carriers based on physical state of drug, particle size distribution and drug-polymer interactions,Search in Google Scholar

Eur. J. Pharm. Biopharm. 66 (2007) 334-347; DOI: 10.1016/j.ejpb.2006.11.020.10.1016/j.ejpb.2006.11.020Search in Google Scholar

20. M. N. Reddy, T. Rehana, S. Ramakrishna, K. P. R. Chowdary and P. V. Diwan, b-cyclodextrincomplexes of celecoxib: Molecular-modeling, characterization, and dissolution studies, AAPS Pharm Sci. 6 (2004) 1-9; DOI: 10.1208/ps060107.10.1208/ps060107Search in Google Scholar

21. C. H. Marques, J. Hadgraft and I. Kellaway, Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC, Int. J. Pharm. 63 (1990) 259-266; DOI: 10.1016/0378-5173(90)90132-N.10.1016/0378-5173(90)90132-NSearch in Google Scholar

22. S. Suresh, H. N. Shivakumar and G. K. Kumar, Effect of b-cyclodextrin complexation on the solubility and dissolution rate of carbamazepine from tablets, Ind. J. Pharm. Sci. 68 (2006) 301-307; DOI: 10.4103/0250-474X.26657.10.4103/0250-474X.26657Search in Google Scholar

23. F. F. Eugene and A. H. Timothy, Pre-formulation, in The Theory and Practice of Industrial Pharmacy (Eds. L. Lachmann, H. A. Liberman and J. L. Kanig), 3rd ed., Varghese Publishing House, Mumbai 1987, p. 171.Search in Google Scholar

24. K. Amareshwar and D. K. Rai, Spectroscopic studies of some antidiabetic drugs, Spectrochim. Acta 59 (2003) 1673-1680; DOI: 10.1016/S1386-1425(02)00405-5.10.1016/S1386-1425(02)00405-5Search in Google Scholar

25. I. Bratu, F. Veiga, C. Fernandes, A. Hernanz and J. M. Gavira, Infrared spectroscopic study of triacetyl-b-cyclodextrin and its inclusion complex with nicardipine, Spectroscopy 18 (2004) 459-467; DOI: 10.1155/2004/727869.10.1155/2004/727869Search in Google Scholar